France vs South Sudan: HIV/AIDS deaths averted by antiretroviral therapy
France
5,635 deaths
in 2022
South Sudan
6,931 deaths
in 2024
France rank
32nd
South Sudan rank
29th
HIV/AIDS deaths averted by antiretroviral therapy over time
- France
- South Sudan
How they compare
South Sudan currently reports 6,931 deaths against 5,635 deaths in France, a difference of 1,296 deaths.
That makes South Sudan's figure about 1.2 times France's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was South Sudan ahead.
France ranks 32nd and South Sudan ranks 29th of 157 countries.
France has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | France | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 869.7 deaths | 0 deaths | 869.7 deaths | France |
| 2000s | 5,347 deaths | 53.17 deaths | 5,294 deaths | France |
| 2010s | 6,037 deaths | 2,048 deaths | 3,989 deaths | France |
| 2020s | 5,744 deaths | 4,647 deaths | 1,096 deaths | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, France or South Sudan?
- South Sudan, at 6,931 deaths against 5,635 deaths in France as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between France and South Sudan?
- 1,296 deaths, with South Sudan ahead.
- How many years of comparable data are there for France and South Sudan?
- 33 years are reported by both, from 1990 to 2022.
- How do France and South Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- France ranks 32nd and South Sudan ranks 29th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.